Remegen Co., Ltd.

This early-stage study is testing a new drug called RC148, given either alone or with other treatments, for people with advanced non-small cell lung cancer that has spread or cannot be removed by surgery. The main goals are to see if the treatment is safe and if it helps shrink o…

This study is testing two different drug combinations for people with advanced stomach cancer that has spread. Researchers want to see if adding newer targeted drugs to standard treatments works better and is safe. The trial includes 201 adults who haven't had previous treatment …

This study is testing if a drug called telitacicept, given as a weekly injection, can help slow down kidney damage in people with IgA nephropathy, a serious kidney disease. It involves 318 adults whose disease is progressing despite standard medication. The main goal is to see if…